Pfizer, ADA Health Launch the COVID-19 Care Journey
Pfizer and Ada Health have announced the launch of COVID-19 Care Journey, a platform to connect patients to antiviral therapy treatment options. The platform is designed to help people understand if they meet current criteria for progression to severe COVID-19 and connect with a health care provider for evaluation of their COVID-19 symptoms and treatment options.
"Tackling conditions such as COVID-19 swiftly and effectively is imperative to improving people's wellbeing and livelihoods, as well as alleviating the immense pressure it puts on global health systems and economies" said Daniel Nathrath, CEO and co-founder of Ada. "The Ada COVID-19 Care Journey aims to significantly reduce the time from testing to treatment for users, and we firmly believe that it has the potential to improve health outcomes for millions."
The platform hosts an independent telehealth and ePharmacy provider option. The care journey allows users to:
Learn whether they are at high risk of developing severe COVID-19 using a convenient, personalized self-assessment tool based on CDC, FDA and NIH guidelines.
Assess their options for consulting a healthcare provider if they test positive.
Connect to a healthcare provider through telehealth, to assess their symptoms and treatment eligibility within 2 hours, for a low out-of-pocket cost.
If prescribed, obtain a prescription for an authorized oral treatment for COVID-19 for same-day pick up at a local pharmacy. There are plans to expand the platform to offer the option of home medication delivery.
Users can access the Ada COVID-19 Care Journey via Ada's dedicated COVID-19 Care Journey website, by conducting a self-screening in the Ada app, or by following a symptom assessment in the Ada app which indicates COVID-19 as a possible condition.
Join the HealthXL Meeting on ‘Digital Biomarkers for Mental Health Evaluation and Management’ on 16th February. Click here to Request to Join.
Click here to read the original news story.